Add BrightSurf on Google Email

deCODE genetics


Lethal mutations in pregnancy loss

A recent study published in Nature found that millions of pregnancies worldwide are lost each year due to new mutations in the fetus. The researchers discovered that essential genomic sequences are more frequently mutated in lost fetuses compared to adults.

SourcedeCODE genetics·JournalNature·DateMay 21, 2025

New study explores the role of BMI in disease risk

A new study from deCODE genetics/Amgen highlights the importance of Body Mass Index (BMI) in disease pathology, suggesting that reducing BMI could lower the risk of various diseases. For some conditions like fatty liver disease and glucose intolerance, the genetic link to disease disappears when BMI is taken into account.

SourcedeCODE genetics·JournalNature Communications·DateNov 12, 2024

Discovery of cancer risk associations for six novel genes

Researchers identified six novel genes associated with a significant increase in cancer risk, including BIK for prostate cancer, ATG12 for colorectal cancer, and CMTR2 for lung and melanoma. Loss of AURKB was found to protect against any cancer type, while loss of PPP1R15A was linked to a 53% lower risk of breast cancer.

SourcedeCODE genetics·JournalNature Genetics·TypeMeta-analysis·DateOct 29, 2024

Variants in the genome affect DNA methylation

Scientists at deCODE Genetics found that genome variants drive the correlation between DNA methylation and gene expression. The research uses new nanopore sequencing technology to analyze DNA sequences in real-time, revealing a link between noncoding sequence variants and diseases.

SourcedeCODE genetics·JournalNature Genetics·TypeMeta-analysis·DateJul 24, 2024

1 in 25 carries a genotype that is associated with a shortened lifespan

A recent study published in the New England Journal of Medicine found that 4% of Icelanders carry an actionable genotype associated with increased risk of cardiovascular, cancer, and metabolic diseases. These genotypes can lead to a three-year shorter median survival for carriers, particularly those with cancer-predisposing variants.

SourcedeCODE genetics·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateNov 8, 2023

Variants in the genome interact with each other and with the environment to affect the risk of cardiovascular disease

A recent study published in Cell found that genetic variants can influence the risk of cardiovascular disease by interacting with environmental factors. For example, carriers of certain sequence variants are protected against the negative effects of alcohol consumption on coronary artery disease.

SourcedeCODE genetics·JournalCell·TypeData/statistical analysis·DateSep 14, 2023

Knowledge that can improve identification and risk stratification of a heart disorder that can cause sudden cardiac death

Researchers identified 12 rare genetic variants associated with QT interval prolongation, increasing the risk of severe heart rhythm abnormalities and sudden cardiac death. These variants can lead to a more precise clinical approach through improved identification and risk stratification, aligning with precision medicine principles.

SourcedeCODE genetics·JournalJournal of the American Heart Association·TypeMeta-analysis·DateJul 26, 2023

First genetic locus for voice pitch

Scientists have identified a genetic locus associated with voice pitch, found in the ABCC9 gene, which influences voice characteristics in both men and women. The study also reveals links between voice pitch and cardiovascular health, highlighting the complex relationship between vocal traits and human biology.

SourcedeCODE genetics·JournalScience Advances·TypeData/statistical analysis·DateJun 9, 2023

CRTAC1 is a promising biomarker of osteoarthritis

A study published in Arthritis & Rheumatology has identified CRTAC1 as a specific biomarker of osteoarthritis, associated with both prevalent and incident knee and hip OA. The protein is also a strong predictor of progression to joint replacements, holding promise for early diagnosis and treatment.

SourcedeCODE genetics·JournalArthritis & Rheumatology·TypeMeta-analysis·DateOct 17, 2022

deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer

Scientists from deCODE genetics and academic colleagues report discovering genetic markers that impact individual baseline levels of prostate-specific antigen (PSA). Analyzing four SNPs in tandem with genetic risk factors detected by the deCODE ProstateCancer test yields substantial improvement in PSA screening efficacy.

SourcedeCODE genetics·JournalScience Translational Medicine·DateDec 15, 2010